Category: Drug Discovery
Global Drug Discovery
-
Organoids Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells), and Geography
... Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells), and Geography The organoids market is expected to grow from US$ 2.50 billion in 2022 to US$ ... Read More
-
Gastrointestinal Drugs Market Covering Antacids; Antiulcerants; Antiemetics And Antinauseants; Antidiarrhoeals; Global Summary 2023
... In terms of per capita consumption, the market was $9.7 and in terms of global GDP, the market was 0.07%. Gastrointestinal drugs was the eighth largest segment within the market accounting for 4.7% preceded and ... Read More
-
Dermatology Drugs Market Covering Acne; Dermatitis; Psoriasis; Alopecia; Global Summary 2023
... of per capita consumption, the market was $7.1 and in terms of global GDP, the market was 0.05%. Dermatology drugs was the tenth largest segment within the market accounting for 3.4% preceded and followed by ... Read More
-
Global HIV Treatment Market: Analysis By Product (Atripla, Biktarvy, Descovy, Genovya, Odefsey, Truvada, Sunlenca (Lenacapavir), Dovato, Juluca, Tivicay, Triumeq, Cabenuva, VH184, Capsid, bNAbs, Islatravir, and Generics), By Region (The US, and EU + ROW) Size and Trends with Impact of COVID-19 and Forecast up to 2030
... and Trends with Impact of COVID-19 and Forecast up to 2030 The global HIV treatment market in 2022 stood at US$22.38 billion, and is likely to reach US$25.49 billion by 2030. HIV treatment, also known ... Read More
-
Global Pulmonary Arterial Hypertension (PAH) Market: Analysis By Drug Class (Prostacyclin and Prostacyclin Analogs, Endothelin Receptor Antagonists (ERAs), sGC Stimulators, and pde-5 Inhibitors), By Type (Branded and Generic), By Route of Administration (Oral, Intravenous/ Subcutaneous, and Inhalation), By Distribution Channel (Hospital Pharmacies and Clinic, Retail Pharmacies, and Online Pharmacies), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028
... and Inhalation), By Distribution Channel (Hospital Pharmacies and Clinic, Retail Pharmacies, and Online Pharmacies), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028 The global pulmonary arterial hypertension market was ... Read More
-
Cardiovascular Drugs Market Covering Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Angina Pectoris; Congestive Heart Failure; Other Drugs For Cardiovascular Diseases (Anti-Arrhythmic And Anti-Anginal Drugs); Global Summary 2023
... 2022. It was the fifth largest segment within the market accounting for 9.6%. In terms of per capita consumption, the market was $19.8 and in terms of global GDP, the market was 0.14%. Cardiovascular drugs ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Post-Traumatic Stress Disorder (PTSD) Clinical trials scenario. This report provides top line data ... Read More
-
Antihyperlipidemic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 16.0 Billion by 2028, exhibiting a growth rate (CAGR) of 4.6% during 2023-2028. Antihyperlipidemic drugs help lower serum levels of cholesterol and various lipids in the blood. They can be taken with different ... Read More
-
Anti-Obesity Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 4.0 Billion by 2028, exhibiting a growth rate (CAGR) of 11.7% during 2023-2028. Anti-obesity drugs are intended to reduce or control weight and generally medically prescribed only in cases of morbid obesity. They ... Read More
-
Global Systemic Lupus Erythematosus Market - 2023-2030
... by 2030. The systemic lupus erythematosus market is expected to exhibit a CAGR of 7.3% during the forecast period (2023-2030). Systemic lupus erythematosus (SLE) is a chronic autoimmune condition that can harm the skin, joints, ... Read More
-
Next Generation Antibody Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price ... Read More
-
Global Acute Myeloid Leukemia Market Size Study & Forecast, By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy, Other Chemotherapies), and Regional Analysis, 2023-2030
... at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Acute Myeloid Leukemia (AML) is a form of blood ... Read More
-
Quantum Computing in Healthcare Market by Component (Hardware, Software), Deployment (0n-premises, Cloud-based), Technology (Superconducting qubits, Trapped ions), Application (Drug discovery, Genomics), End User, and Region - Global Forecast to 2028
... healthcare market is projected to reach USD 503 million by 2028 from USD 85 million in 2023, at a high CAGR of 42.5% during the forecast period. The technological advancements in quantum computing supporting various ... Read More
-
Global Artificial Intelligence-driven Drug Development Market Growth (Status and Outlook) 2023-2029
... it is expected to grow at a CAGR of 31.8% from 2023 to 2029. United States market for Artificial Intelligence-driven Drug Development is estimated to increase from US$ million in 2022 to US$ million by ... Read More
-
Global Invasive Fungal Infections Market: Analysis By Molecule Class (Azoles, Echinocandins, Allylamines/Pyrimidines, Polyenes and Others), By Infection Type (Candidiasis, Aspergillosis, Cryptococcus, and Other), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028
... to 2028 Invasive fungal infections (IFIs) are serious and potentially life-threatening infections caused by fungi that invade deep tissues, organs, or the bloodstream of the human body. These infections can occur in individuals with weakened ... Read More
-
Global Artificial Intelligence in Drug Discovery and Development Market Growth (Status and Outlook) 2023-2029
... to US$ 9235.1 million in 2029; it is expected to grow at a CAGR of 31.8% from 2023 to 2029. United States market for Artificial Intelligence in Drug Discovery and Development is estimated to increase ... Read More
-
Global Central Nervous System Biomarkers Market Size study & Forecast, by Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers, Others) by Application (Drug Discovery and Development, Personalized Medicine, Other Applications), by End User (Diagnostic Labs, Clinics/Hospitals, Research Centers) and Regional Analysis, 2022-2029
... Research Centers) and Regional Analysis, 2022-2029 Global Central Nervous System Biomarkers Market is valued approximately at USD 4.19 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.00% ... Read More
-
Global Precision Medicine Market Size study & Forecast, by Technology ( Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics and Other Technologies) by Application ( Oncology, CNS, Immunology, Respiratory and Other Applications), and Regional Analysis, 2022-2029
... Regional Analysis, 2022-2029 Global Precision Medicine Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Precision ... Read More
-
Global Software as a Medical Device Market Size study & Forecast, by Device Type (Smartphones, Laptops/Desktops, Wearable Devices) by Software Technology (Artificial Intelligence, Machine Learning), by Application (Screening and Diagnosis, Monitoring and Alerting, Chronic Condition & Disease Management, Digital Therapeutics) and Regional Analysis, 2022-2029
... & Disease Management, Digital Therapeutics) and Regional Analysis, 2022-2029 Global Software as a Medical Device Market is valued approximately at USD XX billion in 2021 and is anticipated to grow with a healthy growth rate ... Read More
-
Global AI In Genomics Market Size study & Forecast, by Component (Hardware, Software, Services), By Technology (Machine Learning, Computer Vision), By Functionality (Genome Sequencing, Gene Editing, Others), By Application (Drug Discovery & Development, Precision Medicine, Diagnostics, Others), By End-use (Pharmaceutical and Biotech Companies, Healthcare Providers, Research Centers, Others), and Regional Analysis, 2022-2029
... Diagnostics, Others), By End-use (Pharmaceutical and Biotech Companies, Healthcare Providers, Research Centers, Others), and Regional Analysis, 2022-2029 Global AI In Genomics Market is valued at approximately USD 341.03 million in 2021 and is anticipated to ... Read More
-
Global Ophthalmic Disease Therapeutics Market Size Study & Forecast, by Drug Class (Anti-inflammatory, Anti-invectives, Anti-VEGF and Others) by Dosage Form (Solid, Liquid and Semisolid), by Disease Indication (Glaucoma, Dry Eye Disease, Retinal Disease, Allergy & Infections and Others), by Distribution Channel (Hospital Pharmacies, Retail & Online Pharmacies) and Regional Analysis, 2022-2029
... Infections and Others), by Distribution Channel (Hospital Pharmacies, Retail & Online Pharmacies) and Regional Analysis, 2022-2029 Global Ophthalmic Disease Therapeutics Market is valued at approximately USD 31.54 billion in 2021 and is anticipated to grow ... Read More
-
Global Artificial Intelligence in Drug Discovery Market Insights, Forecast to 2029
... US$ 1,786.76 million in 2023 to US$ 8,890.05 million by 2029, at a Compound Annual Growth Rate (CAGR) of 30.66% during the forecast period. The global key companies of Artificial Intelligence in Drug Discovery include ... Read More
-
Genomics Market by Product & Service (Consumables, Instrument, System & Software), Technology (Sequencing, PCR, Microarray), Study Type (Epigenomics, Biomarker Discovery), Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2028
... projected to reach USD 83.1 billion by 2028 from USD 46.2 billion in 2023, at a CAGR of 12.4% during the forecast period of 2023 to 2028. . Continuous developments in sequencing technologies and a ... Read More
-
Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... total prevalent cases of BDD in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. No approved marketed drugs are currently available for the treatment of BDD. R&D activity within the BDD space is ... Read More
-
BiSpecific mAbS Global Market Opportunities And Strategies To 2032
... need to assess the global bi-specific mAbS market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12 ... Read More
Research Assistance
